Best Ovarian Biopsy Doctors Abroad

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Doyoung Jeong is an obstetrician-gynecologist at Seoul Miz Hospital. He specializes in single-port robotic and minimally invasive surgery for uterine and ovarian diseases. Dr. Jeong holds multiple patents for specialized single-port surgical devices. He is a full member of the International Society of Ultrasound in Obstetrics and Gynecology.

• Served as Director and Chief Medical Officer at Incheon Sejong Hospital.
• Former Vice President at Dongtan Jeil Hospital.
• Clinical Professor at Kyung Hee University Hospital and Adjunct Professor at Korea University.
• Acts as a clinical medical device expert for the Ministry of Food and Drug Safety.

Dr. Paul Stanciu is the first gynecologist worldwide accredited to operate on two different robotic platforms. He specializes in gynecological oncology and robotic surgery at Ponderas Academic Hospital. Dr. Stanciu trained at renowned centers including The Royal Marsden Hospital in the UK.

• Holds certifications from SERGS, ESGO, BSCCP, and IOTA.
• Performs complex procedures for endometriosis and fertility-sparing cancer surgery.
• Delivered over 100 presentations at national and international medical conferences.
• Works at a JCI-accredited hospital designated as a Robotic Surgery Center of Excellence.

Prof. Dr. Erdoğan Aslan is an Obstetrics and Gynecology specialist with more than 25 years of experience. He practices at Optimed International Hospital.

He graduated from Ege University Faculty of Medicine in 1993. He completed his specialist training in Obstetrics and Gynecology at SSK Göztepe Training and Research Hospital in 2001. He then pursued clinical fellowships at St. George’s Hospital in London.

He is a Professor and former Vice Rector at Alanya Alaaddin Keykubat University. He also served on the faculty at Baskent University and Mustafa Kemal University. His core expertise includes urogynecology, gynecologic oncology, and cosmetic gynecology. He is a member of the Turkish Medical Association. He is also a member of the Turkish Urogynecology and Pelvic Reconstructive Surgery Association, the International Urogynecology Association, the Turkish Gynecological Oncology Association, and the Gynecological Endoscopy Association.

Dr. Antonio Gosálvez Vega directs the Assisted Reproduction Unit at Quironsalud Madrid. He specializes in IVF and complex fertility treatments. He is a member of the American Society for Reproductive Medicine. Dr. Vega treats conditions like endometriosis and polycystic ovaries at Spain's top-ranked hospital.

• Performs robotic sacrohysteropexy and laparoscopic surgery for endometriosis.
• Provides PRP ovarian rejuvenation and bioidentical hormone replacement therapy.
• Former professor of the Master in Human Reproduction at Complutense University.
• Maintains membership in the European Society of Human Reproduction.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Dr. Brenda Pastrana is a surgical oncologist at the JCI-accredited Galenia Hospital in Cancún. She specializes in breast, thyroid, and digestive system cancers. Dr. Pastrana is board-certified by CONACEM. She holds a medical degree from the Universidad Autónoma de México.

• Performs mastectomies, liver resections, and complex colon cancer surgeries.
• Treats patients at a facility holding Accreditation Canada Diamond Status.
• Serves as a university teacher at Universidad Anáhuac.
• Member of the Mexican Society of Oncology (SMEO).

Dr. Alper Sismanoglu is a fertility specialist and obstetrician-gynecologist in Istanbul. He has performed over 4,000 IVF treatments with a 65% success rate. Dr. Sismanoglu serves as an Assistant Professor at Istanbul Altinbas University. He founded the Arti IVF Clinic to treat international patients.

• Member of the European Society of Human Reproduction and Embryology (ESHRE).
• Performs egg cryopreservation, embryo transfer, and infertility surgery.
• Treats reproductive conditions including endometriosis and polycystic ovaries.
• Authored over 20 peer-reviewed studies in international medical journals.

Dr. Mine Daggez is a gynecologic oncologist at Biruni University Hospital in Istanbul. She specializes in robotic surgery and minimally invasive cancer treatments. Dr. Daggez completed cancer surgery training at Charité Berlin. She currently pursues a PhD in molecular oncology to improve surgical results.

• Performs robotic hysterectomy and laparoscopic gynecological cancer surgery.
• Treats deep infiltrative endometriosis and complex placental adhesion anomalies.
• Specializes in cervical dysplasia and HPV diagnosis using colposcopy.
• Works at Biruni University Hospital, a TEMOS-accredited facility in Turkey.

Dr. Engin Oral is a fertility specialist and gynecologist at Biruni University Hospital in Istanbul. He is the founder of the Endometriosis and Adenomyosis Association of Turkey. Dr. Oral completed a fellowship in reproductive endocrinology at Yale University School of Medicine. He currently serves as a Professor at Biruni University Faculty of Medicine.

• Specializes in IVF, polycystic ovary syndrome, and laparoscopic surgery for endometriosis.
• Maintains a Google Scholar H-index of 30, reflecting significant scientific contributions.
• Performs complex procedures including laparoscopic hysterectomy and hysteroscopic septum resection.
• Works at Biruni University Hospital, which holds TEMOS international healthcare accreditation.

Dr. Namrata Narendra Jadhav is an obstetrician and gynecologist at Dubai London Hospital. She focuses on high-risk obstetrics and cosmetic gynecology. Dr. Jadhav trained at top medical institutions in Mumbai and the UAE. She successfully manages pregnancies complicated by hypertension, diabetes, and previous cesarean sections.

• Completed specialized laparoscopic training in both 2016 and 2022.
• Treats reproductive health issues like endometriosis, PCOS, and uterine fibroids.
• Performs cosmetic gynecological procedures and surgical removals like myomectomies.
• Practices at JCI-accredited Dubai London Hospital in the United Arab Emirates.

Dr. Jelena Jevtic Akif is a specialist obstetrician and gynecologist at Dubai London Hospital. She focuses on gynecological endocrinology and prenatal care. She has held teaching roles as a professor of gynecology in Belgrade. Dr. Akif treats complex conditions like uterine fibroids and endometriosis. She works at a JCI-accredited facility that treats 110,000 patients annually.

• Specializes in laser treatments for stress urinary incontinence and vaginal rejuvenation.
• Performs 4D ultrasound and invasive diagnostic procedures like hysteroscopy.
• Treats lower genital tract pathology and vaginal relaxation syndrome.
• Expert in surgical procedures including myomectomy and Cesarean sections.

Dr. Turkan Ozturk Topcu is a clinical oncologist at Biruni University Hospital in Istanbul. She maintains professional ties with the MD Anderson Cancer Center in the USA. She specializes in the treatment of breast, lung, and gastrointestinal cancers. Dr. Topcu is a member of both ESMO and ASCO.

• Completed a fellowship at the Sunnybrook Odette Cancer Center Breast Clinic in Canada.
• Treats a wide range of conditions including liver, pancreatic, and gynecological cancers.
• Held clinical roles at major institutions like Moffitt Cancer Center in the USA.
• Works at Biruni University Hospital, a TEMOS-accredited facility in Turkey.

Dr. Mehmet Tufan Babayigit has performed over 15,000 IVF trials throughout his career. He specializes in gynecological oncology and reproductive endocrinology at Avicenna International Hospital. Dr. Babayigit completed training in IVF and reproductive endocrinology at Tel Aviv University in Israel. He previously managed the Gynecological Oncology and IVF Center at Bodrum Acibadem Hospital.

• Practiced and studied in the UK, Saudi Arabia, Greece, and Russia.
• Treats complex conditions including uterine fibroids, endometriosis, and polycystic ovaries.
• Performs procedures including laparoscopic hysterectomy and ovarian rejuvenation.
• Works at an Istanbul-based hospital treating 175,000 patients annually.

Dr. Rajesh Devassy is a gynecologic oncologist at Dubai London Hospital. He has performed over 38,000 laparoscopic surgeries throughout his career. Dr. Devassy specializes in laparoscopic pelvic reconstructive and oncological surgery. He treats complex conditions like endometriosis, uterine fibroids, and ovarian cysts.

• Serves as an Overseas Advisory Board Member of the European Society for Gynaecological Endoscopy.
• Acts as an International Course Director at Pius Hospital, University Hospital in Germany.
• Leads the GESEA Training Centre, one of only two European-accredited centers in the region.
• Sits on the board of the Emirates Minimal Invasive Surgery Club.

Dr. Pasquale Totaro is a reproductive endocrinologist at Ospedale Santa Maria in Bari. He coordinates a fertility center performing 1,000+ procedures every year. Under his leadership, the hospital ranks first in Italy for intrauterine insemination (IUI) cycles. Dr. Totaro specializes in medically assisted procreation and obstetrics-gynecological ultrasound.

• Ranks 4th nationally for oocyte thawing procedures.
• Authored over 30 scientific publications on reproductive medicine.
• Active member of the European Society of Human Reproduction and Embryology (ESHRE).
• Performs complex procedures including IVF, egg cryopreservation, and robotic myomectomy.

Dr. Elnur Sahibov is a specialist in radiation oncology at Emsey Hospital. He completed his medical training at the Marmara University Faculty of Medicine.

• Specialized in radiation oncology at Marmara University
• Practices at Emsey Hospital in Istanbul
• Completed medical school training in English
• Focuses on oncology cases requiring ovarian biopsy for diagnosis

Dr. Tanut Jerachotechueantaveechai is a fertility specialist and Medical Director at Bangkok Central Clinic. He led several fertility centers to achieve JCI accreditation. This is a global gold standard for patient safety and care. Dr. Tanut graduated with First-Class Honors from Mahidol University.

• Specializes in IVF, embryo biopsy, and blastocyst vitrification.
• Treats reproductive conditions including endometriosis, polycystic ovaries, and uterine fibroids.
• Completed cytogenetics training at Ramathibodi Hospital and a menopause preceptorship.
• Presented research at ESHRE meetings in Spain and Austria.

Prof. Mesut Polat specializes in gynecologic oncology and advanced surgical techniques at Medipol Acibadem District Hospital. He performs ovarian biopsy procedures using minimally invasive methods to diagnostic cancer.

• Expert in gynecologic oncology – treats tumors of the female reproductive system
• Specializes in minimally invasive surgery to reduce recovery time and scarring
• Published 19 international articles in peer-reviewed medical journals
• Member of the Turkish Society of Obstetrics and Gynecology
• Former administrative lead at Zeynep Kamil Women and Children Diseases Hospital